These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28744716)

  • 1. Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers.
    Petrik AF; Le T; Keast E; Rivelli J; Bigler K; Green B; Vollmer WM; Coronado G
    J Community Health; 2018 Feb; 43(1):128-136. PubMed ID: 28744716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Colorectal Cancer Screening in Federally Qualified Health Centers.
    Riehman KS; Stephens RL; Henry-Tanner J; Brooks D
    Am J Prev Med; 2018 Feb; 54(2):190-196. PubMed ID: 29198834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Reach of a Patient Navigation Program for Follow-up Colonoscopy in a Large Federally Qualified Health Center.
    Gautom P; Rosales AG; Petrik AF; Thompson JH; Slaughter MT; Mosso L; Hussain SA; Jimenez R; Coronado GD
    Cancer Prev Res (Phila); 2024 Jul; 17(7):325-333. PubMed ID: 38641422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
    Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
    J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A statewide program providing colorectal cancer screening to the uninsured of South Carolina.
    Eberth JM; Thibault A; Caldwell R; Josey MJ; Qiang B; Peña E; LaFrance D; Berger FG
    Cancer; 2018 May; 124(9):1912-1920. PubMed ID: 29415338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of screening colonoscopy on outcomes in colorectal cancer.
    Matsuda T; Ono A; Kakugawa Y; Matsumoto M; Saito Y
    Jpn J Clin Oncol; 2015 Oct; 45(10):900-5. PubMed ID: 26254299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
    Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
    Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients.
    Liss DT; Brown T; Lee JY; Altergott M; Buchanan DR; Newland A; Park JN; Rittner SS; Baker DW
    Cancer Causes Control; 2016 Jul; 27(7):881-7. PubMed ID: 27228991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
    Nielson CM; Vollmer WM; Petrik AF; Keast EM; Green BB; Coronado GD
    J Gen Intern Med; 2019 Jun; 34(6):978-985. PubMed ID: 30684199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
    Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
    BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
    Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.